Central Venous Sinus Thrombosis in a Young Woman Taking Norethindrone Acetate for Dysfunctional Uterine Bleeding: Case Report and Review of Literature

Journal of Obstetrics and Gynaecology Canada

Volumn 30, Issue 8, 2008, Pages 680-683

  Rajput, Rajesh ^a   Dhuan, Joginder ^a   Agarwal, Shalini ^a   Gahlaut, P S ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Central venous sinus thrombosis; Hyperhomocysteinemia; Norethindrone acetate

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; NORETHISTERONE ACETATE; PYRIDOXINE; WARFARIN; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CENTRAL VENOUS SINUS THROMBOSIS; CEREBRAL SINUS THROMBOSIS; DISEASE SEVERITY; FEMALE; HEADACHE; HEMIPARESIS; HUMAN; HYPERHOMOCYSTEINEMIA; METRORRHAGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DEFICIENCY; OVARY POLYCYSTIC DISEASE; PHLEBOGRAPHY; SEIZURE; SENSORY DYSFUNCTION; YOUNG ADULT; CHEMICALLY INDUCED DISORDER; MAGNETIC RESONANCE ANGIOGRAPHY; MENORRHAGIA; NUTRITIONAL DISORDER; REVIEW; TREATMENT OUTCOME;

CONTRACEPTIVES, ORAL, SYNTHETIC; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPERHOMOCYSTEINEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MENORRHAGIA; NORETHINDRONE; NUTRITION DISORDERS; POLYCYSTIC OVARY SYNDROME; SINUS THROMBOSIS, INTRACRANIAL; TREATMENT OUTCOME; WARFARIN; YOUNG ADULT;

EID: 58149132328     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32916-4     Document Type: Article

References (9)

1. De Bruijn S., Stam J., Koopman M., Vandenbrouke J. Case-control study of risk of cerebral venous sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions. Br Med J 1998, 316:589-592.
2. De Bruijn S., de Haan R., Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatr 2001, 70:105-108.
3. Einhaupl K., Bousser M.-G., de Bruijn S.F., Ferro J.M., Martinelli I., Masuhr F., et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 2006, 13:553-559.
4. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception A multinational study of cardiovascular disease and steroid hormone contraceptives: description and validation of methods. J Clin Epidemiol 1995, 48:1513-1547.
5. Poulter N.R., Chang C.L., Farley T.M.M., Meirik O. Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications. Lancet 1999, 354(6):1610.
6. Vasilakis C., Jick H., del Mar Melero-Montes M. Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet 1999, 354(6):1610-1611.
7. 12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004, 35:1790-1794.
8. Stam J., de Bruijn S.F., de Veber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002, 4:CD002005.
9. Canhão P., Falcao F., Ferro J.M. Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 2003, 15:159-166.